NEW YORK


,


Dec. 12, 2022


/PRNewswire/ —

Weiss Law

is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Horizon Therapeutics Public Limited Company (“Horizon Therapeutics” or the “Company”) (NASDAQ: HZNP) in connection with the proposed acquisition of the Company by Amgen Inc. (NASDAQ: AMGN).  Under the terms of the merger agreement, the Company’s shareholders will receive

$116.50

in cash for each share of Horizon Therapeutics common stock owned.

If you own




Horizon Therapeutics




shares




and wish to discuss this investigation or have any

questions concerning this notice or your rights or interests, visit our website:

https://www.weisslaw.co/news-and-cases/hznp





Or please contact:





Joshua Rubin, Esq.



Weiss Law

305 Broadway, 7

^th

Floor


New York

, NY  10007


(212) 682-3025



(888) 593-4771


[email protected]

Weiss Law is investigating whether (i) Horizon Therapeutics’ board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the

$116.50

per share merger consideration adequately compensates Horizon Therapeutics’ shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.  Notably, at least one analyst set a price target for the Company of

$140

per share,

$23.50

above the per-share merger consideration.

Weiss Law has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at


[email protected]

View original content to download multimedia:

https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-investigates-horizon-therapeutics-public-limited-company-301700740.html

SOURCE Weiss Law